Xeris Biopharma Holdings Inc. share price logo

Xeris Biopharma Holdings Inc.

NASDAQ: XERS

Small Cap

$8.08

-0.34

(-4.04%)

as on

Xeris Biopharma Holdings Inc. Stock Performance

as on August 1, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $7.99
    $8.39
    downward going graph

    1.11%

    Downside

    3.84%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.87
    $10.08
    downward going graph

    39.73%

    Downside

    24.75%

    Upside

    downward going graph

Xeris Biopharma Holdings Inc. share price movements today

Previous Close
$8.42
Open
$8.39
Volume
1.2M
Day's Low - High
$7.99 - $8.39
52 Week Low - High
$4.87 - $10.08

Xeris Biopharma Holdings Inc. Historical Returns

1 Month Return
+ 1 %
3 Month Return
+ 28.66 %
1 Year Return
+ 50.19 %
3 Year Return
+ 200.37 %
5 Year Return
0 %

Xeris Biopharma Holdings Inc. Stock Fundamentals & Key Indicators

Check Xeris Biopharma Holdings Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

0.1425

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

120.29

Industry PE ratio

1.4176923076923078

PEG Ratio

0

EBITDA

48.1M

Revenue (TTM)

314.9M

Profit Margin

3.81%

Return On Equity TTM

-617.16%

Xeris Biopharma Holdings Inc. Stock Valuation

Track how Xeris Biopharma Holdings Inc. P/E has moved over time to understand its valuation trends.

Xeris Biopharma Holdings Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-68.84x)

September 30, 2025

Industry (1.42x)

August 1, 2026

Today (120.29x)

August 1, 2026

Highest (104.42x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: 120.29x

Xeris Biopharma Holdings Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xeris Biopharma Holdings Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Xeris Biopharma Holdings Inc. image
Xeris Biopharma Holdings Inc.
BUY$1.5BNA120.293.81%NA
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$25.8B184.57%19.1540.62%NA
Viatris Inc. image
Viatris Inc.
HOLD$20.7B24.8%NA-2.04%2.69%
Haleon plc (ADR) image
Haleon plc (ADR)
BUY$43.5BNA20.5614.55%1.91%
ZOETIS INC. image
ZOETIS INC.
BUY$31.9B-61.87%12.7828.04%2.6%
See all

Stock Returns calculator for Xeris Biopharma Holdings Inc. Stock including INR - Dollar returns

The Xeris Biopharma Holdings Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Xeris Biopharma Holdings Inc. investment value today

Current value as on today

₹1,63,667

Returns

₹63,667

(+63.67%)

Returns from Xeris Biopharma Holdings Inc. Stock

₹50,186 (+50.19%)

Dollar Impact

₹13,481 (+13.48%)

Analyst Recommendation on Xeris Biopharma Holdings Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Xeris Biopharma Holdings Inc.. Average target price of $11.29

Xeris Biopharma Holdings Inc. Share Price Target

Get share price movements and forecasts by analysts on Xeris Biopharma Holdings Inc..

What analysts predicted

28.43%UPSIDE

Target Price

$11.29

Current Price

$8.08

Analyzed by

12 Analysts

Target

$11.29

Xeris Biopharma Holdings Inc. target price $11.29, a slight upside of 28.43% compared to current price of $8.08. According to 12 analysts rating.

Indian Investors' Interest in Xeris Biopharma Holdings Inc. Stock

Search interest for Xeris Biopharma Holdings Inc. Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:8% versus previous 30 day period

Xeris Biopharma Holdings Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
44
40
48
54
60
60
71
74
85
83
Gross Profit
34
34
37
40
50
51
56
63
66
69
Operating Income
-9
-14
-8
-12
1
-3
4
6
16
7
EBITDA
-3
-8
-3
-8
5
1
8
11
14
12
Interest Expense
7
7
7
7
7
7
7
7
7
6
Depreciation
3
3
3
3
3
3
3
3
3
3
Income Before Tax
-13
-18
-14
-19
-5
-9
-1
0
11
2
Income Tax Expense
0
0
0
-3
-
-
-
-
-
-
Net Income
-13
-18
-15
-15
-5
-9
-1
0
11
2
Net Profit Margin
-30.16%
-46.71%
-31.22%
-29.00%
-8.51%
-15.34%
-2.70%
0.83%
12.91%
2.69%

Xeris Biopharma Holdings Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
1
2
2
2
49
110
163
203
291
Gross Profit
1
1
2
1
1
36
87
135
166
238
Operating Income
-13
-26
-59
-122
-122
-115
-81
-44
-33
24
EBITDA
-13
-26
-57
-119
-117
-113
-69
-23
-13
12
Interest Expense
0
0
2
7
7
7
14
26
33
29
Depreciation
-
0
0
1
1
1
12
13
12
12
Income Before Tax
-13
-26
-60
-126
-126
-122
-96
-63
-57
0
Income Tax Expense
0
0
1
0
0
0
-1
-1
-2
-
Net Income
-13
-26
-60
-125
-125
-122
-94
-62
-54
0
Net Profit Margin
-1228.74%
-1706.56%
-2437.32%
-4613.52%
-4613.52%
-247.48%
-85.86%
-37.98%
-27.00%
0.19%

Xeris Biopharma Holdings Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-18
-15
-15
-5
-9
-1
0
11
2
Operating Cash Flow
-20
-10
-8
1
-10
0
18
20
9
Investing Cash Flow
-19
4
9
10
0
0
0
0
0
Financing Cash Flow
35
0
0
0
-3
0
13
0
-8
Change in Cash
-4
-5
1
12
-13
0
32
19
0

Xeris Biopharma Holdings Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-26
-60
-125
-91
-122
-94
-62
-54
0
Operating Cash Flow
-24
-56
-104
-80
-95
-102
-47
-36
28
Investing Cash Flow
0
-68
-2
-27
97
34
-6
4
0
Financing Cash Flow
35
128
80
126
27
127
-1
36
11
Change in Cash
9
3
-26
18
29
59
-54
4
39

Global Institutional Holdings in Xeris Biopharma Holdings Inc.

Funds
Holdings
Qube Research & Technologies
2.38%
Two Sigma Investments LLC
1.11%
Bank of America Corp
0.96%
Granahan Investment Management Inc..
0.71%
Northern Trust Corp
0.84%
See all

Xeris Biopharma Holdings Inc. News & Key Events

    Insights on Xeris Biopharma Holdings Inc.

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 3 months, XERS stock has moved up by 28.7%

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, XERS has outperformed top 5 stocks with highest market-cap in its industry

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Viatris Inc. Common Stock has given 99.3% return, outperforming this stock by 49.1%

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 2 quarters, 85.80M → 83.12M (in $), with an average decrease of 3.1% per quarter

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 2 quarters, 11.08M → 2.23M (in $), with an average decrease of 79.8% per quarter

    About Xeris Biopharma Holdings Inc.

    Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
    OrganisationXeris Biopharma Holdings Inc.
    Headquarters1375 West Fulton Street, Chicago, IL, United States, 60607
    IndustryDrug Manufacturers - Specialty & Generic
    CEOMr. John P. Shannon
    E-voting on sharesClick here to vote

    Key Management of Xeris Biopharma Holdings Inc.

    Name

    Title

    Mr. Brian Conner

    SVP of Quality and Chief Compliance & Risk Officer

    Ms. Kendal Korte

    Senior Vice President of Human Resources

    Mr. John P. Shannon

    Chairman & CEO

    Mr. Kevin McCulloch

    President & COO

    Mr. Steven M. Pieper

    Chief Financial Officer

    Ms. Beth P. Hecht J.D.

    Chief Legal Officer & Corporate Secretary

    Dr. Anh T. Nguyen M.B.A., M.D.

    Chief Medical Officer

    Ms. Allison Wey

    Senior Vice President of Investor Relations & Corporate Communications

    FAQs

    What is Xeris Biopharma Holdings Inc. share price today?

    Xeris Biopharma Holdings Inc. share price today is $8.08 as on at the close of the market. Xeris Biopharma Holdings Inc. share today touched a day high of $8.39 and a low of $7.99.

    What is the 52 week high and 52 week low for Xeris Biopharma Holdings Inc. share?

    Xeris Biopharma Holdings Inc. share touched a 52 week high of $10.08 on and a 52 week low of $4.87 on . Xeris Biopharma Holdings Inc. stock price today i.e. is closed at $8.08,which is 19.84% down from its 52 week high and 65.91% up from its 52 week low.

    What is Xeris Biopharma Holdings Inc.'s market capitalisation today?

    Xeris Biopharma Holdings Inc. market capitalisation is $0.00T as on .

    How to invest in Xeris Biopharma Holdings Inc. Stock (XERS) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Xeris Biopharma Holdings Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xeris Biopharma Holdings Inc. Shares that will get you 0.1856 shares as per Xeris Biopharma Holdings Inc. share price of $8.08 per share as on August 1, 2026 at 8:45 am IST.

    What is the minimum amount required to buy Xeris Biopharma Holdings Inc. Stock (XERS) from India?

    Indian investors can start investing in Xeris Biopharma Holdings Inc. (XERS) shares with as little as ₹95.38 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹953.80 in Xeris Biopharma Holdings Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Xeris Biopharma Holdings Inc. share’s latest price of $8.08 as on August 1, 2026 at 8:45 am IST, you will get 1.2376 shares of Xeris Biopharma Holdings Inc.. Learn more about fractional shares .